Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31results about How to "No participation" patented technology

Hand-foot simultaneous exercising device for limb recovery of patient

The invention relates to the technical field of medical treatment. The invention discloses a hand-foot simultaneous exercising device for limb recovery of a patient. The hand-foot simultaneous exercising device comprises a base, the top of an arm exercising plate is bilaterally symmetrically and rotatably connected with two groups of turntables; the bottom of the turntable movably penetrates through the arm exercising plate through a rotating rod and is fixedly provided with a group of driving helical teeth; driven helical teeth are engaged with the sides, away from the left-right center lineof the base, of the driving helical teeth; a fixed rod is fixedly mounted on the rear side surface of the driven helical teeth; a group of gears which are supported above the base through supporting rods are rotatably connected to the right lower side of the fixed rod through a transmission belt; a circle of rotating groove is inwards formed in the side wall, facing the left-right center line direction of the base, of each fixing ring, a rotating gear ring is rotationally connected into the rotating groove, a meshing groove is formed in the side wall, located on the right side of the corresponding gear, of each fixing ring, and the gears and the rotating gear rings in the rotating grooves are conveniently meshed at the meshing grooves through the meshing grooves.
Owner:安徽华中机器人技术开发有限公司

A kind of 1,2,3,4-tetrahydroquinoline derivative and preparation method thereof

ActiveCN104817496BStereoselectivity can be controlledEnantioselectivity can be controlledOrganic chemistryHydrogenChemical compound
The invention discloses a 1, 2, 3, 4-tetradroquinoline derivative and a method for preparing the same. The method for preparing the1, 2, 3, 4-tetradroquinoline derivative which can be a chemical compound shown by a formula I includes a step of enabling a chemical compound shown in a formula II and hydrogen to carry out reduction reaction under the catalysis effects of HB(C<6>F<5>)<2> and styrene to obtain the chemical compound shown in the formula I. Alternately, the method for preparing the 1, 2, 3, 4-tetradroquinoline derivative which can be an optically active chemical compound shown in a formula I includes a step of enabling the chemical compound shown in the formula II and hydrogen to carry out reduction reaction under the catalysis effects of the HB(C<6>F<5>)<2> and a chemical compound shown in a formula III to obtain the optically active chemical compound shown in the formula I. The 1, 2, 3, 4-tetradroquinoline derivative and the method have the advantages that the HB(C<6>F<5>)<2> and the styrene are used as catalysts, quinoline derivatives with different structures are used as substrates, accordingly, the high-yield all-cis 1, 2, 3, 4-tetradroquinoline derivative can be synthesized, and the stereoselectivity of products can be controlled; alternately, the HB(C<6>F<5>)<2> and chiral diene are used as catalysts, the quinoline derivatives with the different structures are used as the substrates, accordingly, the high-yield optically active 1, 2, 3, 4-tetradroquinoline derivative can be synthesized, and the enantioselectivity of products can be controlled.
Owner:INST OF CHEM CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products